MedPath

Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy

Phase 3
Completed
Conditions
Epilepsy, Complex Partial
Registration Number
NCT00056576
Lead Sponsor
Eisai Inc.
Brief Summary

The purpose of this study is to determine whether zonisamide alone is effective as a treatment for epilepsy in newly diagnosed cases.

Detailed Description

Epilepsy is characterized by repeated seizures caused by recurrent, abnormal, and excessive synchronous discharges from cerebral neurons. Seizures may be triggered by various causes such as CNS infections, fever, tumors, toxins, vascular disease, degenerative disease, trauma, or may be idiopathic. The type of seizure is usually defined by the initial event, the duration, alterations of consciousness, patterns of motor activity, and post-ictal symptoms. In addition, certain seizure types have characteristic EEG patterns. The International Classification of Epileptic Seizures classifies seizures as partial or generalized. Partial seizures are further classified as simple partial, complex partial (impaired consciousness), or partial seizures secondarily generalized. All partial seizures have onset in a discrete cortical region. Generalized seizures are bilaterally symmetrical and without focal onset and include absence seizures, myoclonic seizures, clonic seizures, tonic seizures, tonic-clonic seizures, and atonic seizures. The goals of treatment include the prevention of seizures, medical management of seizures, and management of the consequences of epilepsy. The study will be conducted with patients who have new onset epilepsy characterized by complex partial seizures and will attempt to characterize the relationship between zonisamide dose and seizure prevention and demonstrate monotherapy efficacy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
165
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (35)

Suncoast Neuroscience Associates, Inc.

πŸ‡ΊπŸ‡Έ

St. Petersburg, Florida, United States

AMO Corporation

πŸ‡ΊπŸ‡Έ

Tallahassee, Florida, United States

Florida Epilepsy & Seizure Disorder Center, PA

πŸ‡ΊπŸ‡Έ

Tampa, Florida, United States

National Institute of Neurosurgery Epilepsy Center

πŸ‡­πŸ‡Ί

Budapest, Hungary

Tartu University Hospital

πŸ‡ͺπŸ‡ͺ

Tartu, Estonia

Kaunas Medical University Clinics

πŸ‡±πŸ‡Ή

Kaunas, Lithuania

Vilnius University Hospital

πŸ‡±πŸ‡Ή

Vilnius, Lithuania

Institute of Neurology, Psychiatry, and Narcology of AMS Ukraine

πŸ‡ΊπŸ‡¦

Kharkov, Ukraine

Neurology Clinic of San Antonio

πŸ‡ΊπŸ‡Έ

San Antonio, Texas, United States

UAB Epilepsy Center

πŸ‡ΊπŸ‡Έ

Birmingham, Alabama, United States

Coordinated Clinical Research

πŸ‡ΊπŸ‡Έ

San Diego, California, United States

River Hills Health Care

πŸ‡ΊπŸ‡Έ

Cincinnati, Ohio, United States

Westmoreland Neurology Associates, Inc.

πŸ‡ΊπŸ‡Έ

Greensburg, Pennsylvania, United States

Northridge Neurological Center

πŸ‡ΊπŸ‡Έ

Northridge, California, United States

Neurology Associates

πŸ‡ΊπŸ‡Έ

Maitland, Florida, United States

North Alabama Neuroscience

πŸ‡ΊπŸ‡Έ

Huntsville, Alabama, United States

Neurology Clinic, P.C.

πŸ‡ΊπŸ‡Έ

Northport, Alabama, United States

Bay Neurological Institute

πŸ‡ΊπŸ‡Έ

Panama City, Florida, United States

Neurology & Headache Specialist of Atlanta, LLC

πŸ‡ΊπŸ‡Έ

Decatur, Georgia, United States

St. Agnes Health Care, Inc.

πŸ‡ΊπŸ‡Έ

Baltimore, Maryland, United States

Louisville Neuroscience Research Center

πŸ‡ΊπŸ‡Έ

Louisville, Kentucky, United States

The Comprehensive Epilepsy Care Center

πŸ‡ΊπŸ‡Έ

Chesterfield, Missouri, United States

Southern Illinois University School of Medicine Dept. of Neurology

πŸ‡ΊπŸ‡Έ

Springfield, Illinois, United States

CNS Research, INC

πŸ‡ΊπŸ‡Έ

East Providence, Rhode Island, United States

Upstate Clinical Research Center

πŸ‡ΊπŸ‡Έ

Albany, New York, United States

Dent Neurological Institute

πŸ‡ΊπŸ‡Έ

Orchard Park, New York, United States

Epilepsy Institute of North Carolina

πŸ‡ΊπŸ‡Έ

Winston-Salem, North Carolina, United States

Blue Ridge Research Center

πŸ‡ΊπŸ‡Έ

Roanoke, Virginia, United States

University of Wisconsin

πŸ‡ΊπŸ‡Έ

Madison, Wisconsin, United States

Neurology & Neurosurgery Associates of Tacoma, Inc. P.S.

πŸ‡ΊπŸ‡Έ

Tacoma, Washington, United States

Semmelweis University Health Science Faculty

πŸ‡­πŸ‡Ί

Budapest, Hungary

Tallinn Children's Hospital

πŸ‡ͺπŸ‡ͺ

Tallinn, Estonia

Kharkov State Medical University

πŸ‡ΊπŸ‡¦

Kharkov, Ukraine

Epilepsy Center

πŸ‡ΊπŸ‡¦

Kiev, Ukraine

Odessa Medical University

πŸ‡ΊπŸ‡¦

Odessa, Ukraine

Β© Copyright 2025. All Rights Reserved by MedPath